Drew M. Pardoll
Johns Hopkins University · 893 works · 168,060 citations · h-index 165
Top works
- Safety, Activity, and Immune Correlates of Anti–PD-1 Antibody in Cancer
- The blockade of immune checkpoints in cancer immunotherapy
- Safety and Activity of Anti–PD-L1 Antibody in Patients with Advanced Cancer
- PD-1 Blockade in Tumors with Mismatch-Repair Deficiency
- Phase I Study of Single-Agent Anti–Programmed Death-1 (MDX-1106) in Refractory Solid Tumors: Safety, Clinical Activity, Pharmacodynamics, and Immunologic Correlates
- Survival, Durable Tumor Remission, and Long-Term Safety in Patients With Advanced Melanoma Receiving Nivolumab
- Colocalization of Inflammatory Response with B7-H1 Expression in Human Melanocytic Lesions Supports an Adaptive Resistance Mechanism of Immune Escape
- Vaccination with irradiated tumor cells engineered to secrete murine granulocyte-macrophage colony-stimulating factor stimulates potent, specific, and long-lasting anti-tumor immunity.
- Mismatch repair deficiency predicts response of solid tumors to PD-1 blockade
- Role of Bone Marrow-Derived Cells in Presenting MHC Class I-Restricted Tumor Antigens
- Association of PD-1, PD-1 Ligands, and Other Features of the Tumor Immune Microenvironment with Response to Anti–PD-1 Therapy
- Overall Survival and Long-Term Safety of Nivolumab (Anti–Programmed Death 1 Antibody, BMS-936558, ONO-4538) in Patients With Previously Treated Advanced Non–Small-Cell Lung Cancer
- Immune Checkpoint Blockade: A Common Denominator Approach to Cancer Therapy
- B7-Dc, a New Dendritic Cell Molecule with Potent Costimulatory Properties for T Cells
- STATs in cancer inflammation and immunity: a leading role for STAT3
- Interleukin-2 production by tumor cells bypasses T helper function in the generation of an antitumor response
- Targeting the PD-1/B7-H1(PD-L1) pathway to activate anti-tumor immunity
- Immunostimulatory monoclonal antibodies for cancer therapy
- Neoadjuvant PD-1 Blockade in Resectable Lung Cancer
- A fixed site of DNA replication in eucaryotic cells